The trial is seen as a complement to the MAIA trial, which had shown a significant overall survival benefit with daratumumab ...

Saad Z. Usmani, MD, MBA, FACP, myeloma specialist and cellular therapist at Memorial Sloan Kettering Cancer Center, presented the results of the CEPHEUS trial and emphasized the positive impact ...

Results for the company's Cepheus phase 3 trial showed a 60.9% improvement in eliminating cancer cells and a 43% reduction in the cancer progressing or causing death when its treatmentis used in ...

Following the FDA's green light for a combo regimen of Sanofi’s Sarclisa in patients with newly diagnosed multiple myeloma ...

Saad Z. Usmani, MD, MBA, FACP, FASCO, discusses the phase 3 CEPHEUS trial of daratumumab with bortezomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma.

Results for the company's Cepheus phase 3 trial showed a 60.9% improvement in eliminating cancer cells and a 43% reduction in the cancer progressing or causing death when its treatmentis used in ...

Daratumumab plus VRd is a more effective frontline treatment option for patients who cannot undergo immediate transplant, ...

Johnson & Johnson (JNJ) announced results from the Phase 3 CEPHEUS study demonstrating a significant clinical improvement with ...

Matt Dunn's stable has been dealt a tragic blow with star galloper Cepheus having to be put down after suffering an injury at trackwork. The eight-year-old galloper had been a long time favourite for ...

Matt Dunn has paid a heartfelt tribute to his 99-year-old grandmother who passed away this week, decades after she gave him ...

Venus still hovers low in the southwestern sky at dusk a half-hour to 45 minutes after sunset. Saturn is comfortably high up ...